Houdini Bio

Houdini Bio is an early-stage biotechnology company using computational synthetic biology to redesign DNA for improved performance in genetic medicines.

The company is developing approaches to enhance the durability and scalability of gene expression, with potential applications across gene therapies and DNA-based therapeutics.

Houdini Bio is currently operating in stealth and is backed by Future Planet Capital.